20May
Joint venture for scaled production of COVID-19 antibody test kits
Renalytix AI plc has entered into a joint venture with the Icahn School of Medicine at Mount Sinai, Kantaro Biosciences, to develop and scale production.. Read More →
18May
Proposed dual-listing on Nasdaq
Renalytix AI plc announces that it has confidentially submitted a draft registration statement on Form F-1 with the Securities and Exchange Commission... Read More →